Olmesartan Medoxomil 40mg Tablets

Olmesartan Medoxomil 40mg is an angiotensin-receptor blocker used for high blood pressure. It helps maintain pressure control and reduces the strain imposed on the heart and blood vessels by hypertension.
Take with or without food at the same time each day. Allow regular measurements to show the response over the following weeks rather than taking extra doses for isolated high readings. Kidney function and potassium are monitored during treatment changes.
Olmesartan medoxomil is converted to olmesartan, which blocks angiotensin II at AT1 receptors. This reduces vasoconstriction and aldosterone-related effects, lowering blood pressure.
Dizziness, low blood pressure, raised potassium and kidney-function changes can occur. Severe persistent diarrhoea with weight loss, fainting or facial swelling needs prompt assessment.
Do not use during pregnancy. Dehydration, renal artery narrowing and potassium-raising medicines increase risk. Rare sprue-like enteropathy can develop months or years after treatment begins. NSAIDs can reduce the pressure effect and increase renal risk.
Provides sustained blood-pressure reduction, helping reduce the long-term vascular burden of uncontrolled hypertension.
A persistent ACE-inhibitor-type cough is less common because olmesartan does not inhibit bradykinin breakdown.
Olmesartan can rarely cause an enteropathy with chronic diarrhoea and weight loss, even after long-term use.
They can increase hyperkalaemia risk, particularly with impaired kidney function.
No. Severe pressure elevation with chest pain, neurological symptoms or breathlessness needs urgent assessment.
No. Renin-angiotensin blockers can harm fetal development, particularly the kidneys, and treatment must be changed promptly.
Medoxomil: a prodrug group removed when olmesartan is activated. AT1 receptor: the main receptor mediating angiotensin II effects. Enteropathy: disease of the intestinal lining. Hypertension: persistently high blood pressure; AR: Olmesartan Medoxomil 40mg أقراص; FR: Olmesartan Medoxomil 40mg comprimés; PT: Olmesartan Medoxomil 40mg comprimidos; ES: Olmesartan Medoxomil 40mg comprimidos; RU: Olmesartan Medoxomil 40mg таблетки; ID: Olmesartan Medoxomil 40mg tablet; VI: Olmesartan Medoxomil 40mg viên nén; MS: Olmesartan Medoxomil 40mg tablet; TL: Olmesartan Medoxomil 40mg tableta; ZH-SG: Olmesartan Medoxomil 40mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Olmesartan Medoxomil 40mg Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Olmesartan Medoxomil 40mg Tablets